Exane Derivatives’s Enovis ENOV Stock Holding History

Exane Derivatives’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-338	Closed	-$11.5K	–	706
2020 Q1	$11.5K	Hold	338	–	–	﹤0.01%	425
2019 Q4	$21.7K	Hold	338	–	–	﹤0.01%	389
2019 Q3	$16.9K	Hold	338	–	–	﹤0.01%	403
2019 Q2	$16.3K	Hold	338	–	–	﹤0.01%	434
2019 Q1	$17.2K	Hold	338	–	–	﹤0.01%	373
2018 Q4	$12.1K	Hold	338	–	–	﹤0.01%	453
2018 Q3	$21.1K	Hold	338	–	–	﹤0.01%	413
2018 Q2	$18K	Hold	338	–	–	﹤0.01%	436
2018 Q1	$18K	Hold	338	–	–	﹤0.01%	398
2017 Q4	$23K	Hold	338	–	–	﹤0.01%	380
2017 Q3	$24.2K	Hold	338	–	–	﹤0.01%	348
2017 Q2	$22.9K	Hold	338	–	–	﹤0.01%	358
2017 Q1	$22.8K	Hold	338	–	–	0.01%	319
2016 Q4	$20.9K	Hold	338	–	–	﹤0.01%	362
2016 Q3	$18.3K	Hold	338	–	–	﹤0.01%	370
2016 Q2	$15.4K	Sell	338 -84	-20%	-$4.1K	﹤0.01%	350
2016 Q1	$20.8K	Sell	422 -34	-7%	-$1.45K	﹤0.01%	374
2015 Q4	$18.3K	Hold	456	–	–	﹤0.01%	301
2015 Q3	$23.5K	Sell	456 -15	-3%	-$995	﹤0.01%	309
2015 Q2	$37.4K	Hold	471	–	–	﹤0.01%	302
2015 Q1	$38.7K	Sell	471 -1,155	-71%	-$96.8K	﹤0.01%	332
2014 Q4	$144K	Buy	+1,626	New	+$147K	0.02%	249

Other funds holding ENOV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Exane Derivatives's ENOV Position: Q2 2020 in Review

Exane Derivatives sold out of Enovis (ENOV) in Q2 2020, closing a stake of 338 shares — an estimated $11.5K sold.

Exane Derivatives first reported a position in ENOV in Q4 2014 and held it in 22 quarters. The position peaked at $144K in Q4 2014. 254 funds tracked by Wall St. Rank hold ENOV as of Q2 2020.

Exane Derivatives reported no remaining Enovis position as of Q2 2020 after selling out during the quarter.
Exane Derivatives sold 338 Enovis shares in Q2 2020, an estimated $11.5K.
Exane Derivatives first reported a position in Enovis in Q4 2014 and held it in 22 quarters.
Exane Derivatives's Enovis position peaked at $144K in Q4 2014.
254 funds tracked by Wall St. Rank held Enovis as of Q2 2020.

Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.